Related Experiment Video
Updated: Apr 27, 2026
08:55
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
13.8K
Platelet effects on ovarian cancer
Ashley N Davis1, Vahid Afshar-Kharghan2, Anil K Sood3
1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Seminars in Oncology
|July 16, 2014
Summary
Paraneoplastic thrombocytosis, characterized by high platelet counts, is increasingly linked to cancer progression. Understanding its mechanisms is crucial for developing novel ovarian cancer therapies targeting megakaryocytes and platelets.
Area of Science:
- Oncology
- Hematology
- Cancer Biology
Background:
- Platelets and megakaryocytes play critical roles in hemostasis, vascular integrity, angiogenesis, inflammation, immunity, wound healing, and cancer biology.
- Thrombocytosis, high platelet turnover, and activated platelets are implicated in cancer progression and metastasis.
- Understanding paraneoplastic thrombocytosis is essential for developing targeted therapies.
Purpose of the Study:
- To provide an overview of paraneoplastic thrombocytosis in ovarian cancer.
- To discuss the clinical implications, biological significance, and mechanisms of this condition.
Main Methods:
- Literature review and synthesis of existing research on thrombocytosis and ovarian cancer.
- Analysis of the role of megakaryocytes and platelets in malignancy.
Main Results:
- Paraneoplastic thrombocytosis is a significant factor in ovarian cancer progression.
- Megakaryocyte and platelet biology are integral to understanding cancer metastasis.
- Mechanisms underlying paraneoplastic thrombocytosis require further elucidation for therapeutic development.
Conclusions:
- Further research into the mechanisms of paraneoplastic thrombocytosis is needed.
- Targeting megakaryocytes and platelets holds potential for novel ovarian cancer treatments.
- Clinical application of megakaryocyte/platelet-directed therapies necessitates a deeper biological understanding.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
01:22Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
02:07Oogenesis
58.0K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
58.0K
02:49Cancer Therapies
8.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K